Results 281 to 290 of about 40,773 (330)

PCSK9 in T-cell function and the immune response. [PDF]

Biomark Res
Wang Y, Fang X, Liu J, Lv X, Lu K, Lu Y, Jiang Y.   +6 more
europepmc   +1 more source

OSLER and ODYSSEY LONG TERM: PCSK9 inhibitors on the right track of reducing cardiovascular events

, 2015
Mohamed Hassan
openalex   +1 more source

Lipid Profile, PCSK9, ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High-Grade Prostate Cancer and Men At-Risk of Prostate Cancer. [PDF]

Cancer Med
Bergeron AC, Wong-Chong E, Joncas FH, Castonguay C, Calon F, Seidah NG, Blais J, Robitaille K, Bergeron A, Fradet V, Gangloff A.   +10 more
europepmc   +1 more source

Efficacy and outcomes of inclisiran in the management of homozygous and heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Khan Z, Singh A, Haseeb Ur Rasool M, Qasim N, Yafaa Naveed Chaudhary M, Syed S, Riaz M, Rehman W, Rehman I, Islam R, Islam H, Muhammad A, Devi R, Wei CR, Naaz F, Akilimali A.   +15 more
europepmc   +1 more source

PCSK9 with a gain of function D374Y mutation aggravates atherosclerosis by inhibiting PPARα expression. [PDF]

Sci Rep
Cui YF, Chen XC, Mijiti T, Abudurusuli A, Deng LH, Ma X, Chen B.   +6 more
europepmc   +1 more source

PCSK9 V474I germline variant drives breast cancer metastasis. [PDF]

Life Metab
Wang H, Shao Z.
europepmc   +1 more source

PCSK9 inhibitors for LDL lowering

, 2015
James P. Walsh
openalex   +2 more sources

Lipid abnormality in diabetic kidney disease and potential treatment advancements. [PDF]

Front Endocrinol (Lausanne)
Tu QM, Jin HM, Yang XH.
europepmc   +1 more source

Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systematic network meta-analysis. [PDF]

Front Cardiovasc Med
Jiang Y, Wang Y, Ma S, Qian L, Jing Y, Chen X, Yang J.   +6 more
europepmc   +1 more source

Silencing FAF2 mitigates alcohol-induced hepatic steatosis by modulating lipolysis and PCSK9 pathway. [PDF]

Hepatol Commun
Huda N, Kusumanchi P, Jiang Y, Gao H, Thoudam T, Zeng G, Skill NJ, Sun Z, Liangpunsakul S, Ma J, Yang Z.   +10 more
europepmc   +1 more source